Though India has built a robust domestic biosimilar market, its international presence and the ability to lower prices as compared to small molecule generics remain limited.
Without widespread access to biosimilars, thousands of cancer patients are losing their battle. Life-saving treatment is not a privilege but a right. The government should understand this.
Prime Minister KP Sharma Oli’s government is being called ‘Hatyara Sarkar’. Home Minister Ramesh Lekhak has resigned, but the protests continue to intensify.
Gurugram: Stirring a storm in Haryana's real estate circles, the Haryana Shehri Vikas Pradhikaran (HSVP)—the state's urban development agency—has taken on the role of...
In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?
COMMENTS